Yolanda D. Mahnke

8.8k total citations · 3 hit papers
32 papers, 6.4k citations indexed

About

Yolanda D. Mahnke is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yolanda D. Mahnke has authored 32 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Immunology, 14 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in Yolanda D. Mahnke's work include Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (15 papers) and T-cell and B-cell Immunology (15 papers). Yolanda D. Mahnke is often cited by papers focused on Immune Cell Function and Interaction (16 papers), Immunotherapy and Immune Responses (15 papers) and T-cell and B-cell Immunology (15 papers). Yolanda D. Mahnke collaborates with scholars based in United States, Germany and Switzerland. Yolanda D. Mahnke's co-authors include Mario Roederer, Bruce L. Levine, Simon F. Lacey, J. Joseph Melenhorst, Zhaohui Zheng, Carl H. June, Vanessa Gonzalez, David T. Teachey, Nancy Bunin and Anne Chew and has published in prestigious journals such as New England Journal of Medicine, Cell and Nature Medicine.

In The Last Decade

Yolanda D. Mahnke

32 papers receiving 6.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

2014 3.9k citations Zhaohui Zheng, Simon F. Lacey et al. New England Journal of Medicine profile →
The who's who of T‐cell differentiation: Human memory T‐cell subsets

2013 603 citations Yolanda D. Mahnke, Mario Roederer et al. profile →
Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma

2015 434 citations Alfred L. Garfall, Marcela V. Maus et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Yolanda D. Mahnke

Since Specialization

Citations

This map shows the geographic impact of Yolanda D. Mahnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda D. Mahnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda D. Mahnke more than expected).

Fields of papers citing papers by Yolanda D. Mahnke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolanda D. Mahnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda D. Mahnke. The network helps show where Yolanda D. Mahnke may publish in the future.

Co-authorship network of co-authors of Yolanda D. Mahnke

This figure shows the co-authorship network connecting the top 25 collaborators of Yolanda D. Mahnke. A scholar is included among the top collaborators of Yolanda D. Mahnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolanda D. Mahnke. Yolanda D. Mahnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Cellular Immune Response to Adeno-Associated Virus-Based Gene Therapy 2023 ·The AAPS Journal ·Boris Gorovits, (unknown), George Buchlis, Michele Fiscella, Travis Harrison, (unknown), Sylvia Janetzki, Vibha Jawa, Brian Long, Yolanda D. Mahnke, Andrew J. McDermott, Mark Milton, Robert Nelson, Christian Vettermann, Bonnie Wu	18
2	Translational immune correlates of indirect antibody immunization in a randomized phase II study using scheduled combination therapy with carboplatin/paclitaxel plus oregovomab in ovarian cancer patients 2020 ·Cancer Immunology Immunotherapy ·Alessandra Battaglia, Alexia Buzzonetti, Marco Fossati, Giovanni Scambia, Andrea Fattorossi, (unknown), Yolanda D. Mahnke, Christopher F. Nicodemus	19
3	Reconstitution of Peripheral T Cells by Tissue-Derived CCR4+ Central Memory Cells Following HIV-1 Antiretroviral Therapy 2016 ·SHILAP Revista de lepidopterología ·Yolanda D. Mahnke, Kipper Fletez‐Brant, Irini Sereti, Mario Roederer	12
4	The Genetic Architecture of the Human Immune System: A Bioresource for Autoimmunity and Disease Pathogenesis 2015 ·Cell ·Mario Roederer, Lydia Quaye, Massimo Mangino, Margaret H. Beddall, Yolanda D. Mahnke, Pratip K. Chattopadhyay, Isabella Tosi, L Napolitano, Manuela Terranova Barberio, Cristina Menni, Federica Villanova, Paola Di Meglio, Tim D. Spector, Frank O. Nestlé	203
5	Chimeric Antigen Receptor T Cells against CD19 for Multiple Myeloma breakdown → 2015 ·New England Journal of Medicine ·Alfred L. Garfall, Marcela V. Maus, Wei‐Ting Hwang, Simon F. Lacey, Yolanda D. Mahnke, J. Joseph Melenhorst, Zhaohui Zheng, Dan T. Vogl, Adam D. Cohen, Brendan M. Weiss, Karen Dengel, Naseem Kerr, Adam Bagg, Bruce L. Levine, Carl H. June, Edward A. Stadtmauer	434
6	Quantifying spillover spreading for comparing instrument performance and aiding in multicolor panel design 2013 ·Cytometry Part A ·Richard Nguyen, Stephen P. Perfetto, Yolanda D. Mahnke, Pratip K. Chattopadhyay, Mario Roederer	84
7	OMIP‐017: Human CD4⁺ helper T‐cell subsets including follicular helper cells 2013 ·Cytometry Part A ·Yolanda D. Mahnke, Margaret H. Beddall, Mario Roederer	53
8	Early immunologic and virologic predictors of clinical HIV-1 disease progression 2012 ·AIDS ·Yolanda D. Mahnke, Kaimei Song, Mariana M. Sauer, Martha Nason, (unknown), Karina I. Carvalho, Priscilla R. Costa, Mario Roederer, Esper G. Kallás	12
9	OMIP‐013: Differentiation of human T‐cells 2012 ·Cytometry Part A ·Yolanda D. Mahnke, Margaret H. Beddall, Mario Roederer	17
10	Human melanoma-specific CD8⁺T-cells from metastases are capable of antigen-specific degranulation and cytolysis directly ex vivo 2012 ·OncoImmunology ·Yolanda D. Mahnke, Estelle Devêvre, Petra Baumgaertner, Maurice Matter, Nathalie Rufer, Pedro Romero, Daniel E. Speiser	13
11	Age-related changes in durability and function of vaccine-elicited influenza-specific CD4+ T-cell responses 2011 ·Vaccine ·Yolanda D. Mahnke, (unknown), (unknown), Rebecca C. Brady, Mario Roederer, Ramu A. Subbramanian	17
12	OMIP‐001: Quality and phenotype of Ag‐responsive human T‐cells 2010 ·Cytometry Part A ·Yolanda D. Mahnke, Mario Roederer	25
13	In Vivo Persistence of Codominant Human CD8+ T Cell Clonotypes Is Not Limited by Replicative Senescence or Functional Alteration 2007 ·The Journal of Immunology ·Laurent Derré, (unknown), Petra Baumgaertner, Estelle Devêvre, Patricia Corthésy, Cédric Touvrey, Yolanda D. Mahnke, Hanspeter Pircher, Verena Voelter, Pedro Romero, Daniel E. Speiser, Nathalie Rufer	23
14	Optimizing a Multicolor Immunophenotyping Assay 2007 ·Clinics in Laboratory Medicine ·Yolanda D. Mahnke, Mario Roederer	153
15	LiveCount Assay: Concomitant measurement of cytolytic activity and phenotypic characterisation of CD8+ T-cells by flow cytometry 2006 ·Journal of Immunological Methods ·Estelle Devêvre, Pedro Romero, Yolanda D. Mahnke	20
16	Maintenance of long‐term tumour‐specific T‐cell memory by residual dormant tumour cells 2005 ·Immunology ·Yolanda D. Mahnke, Jochen Schwendemann, Philipp Beckhove, Volker Schirrmacher	61
17	Recent advances in tumour antigen‐specific therapy: In vivo veritas 2004 ·International Journal of Cancer ·Yolanda D. Mahnke, Daniel E. Speiser, Immanuel F. Luescher, Jean‐Charles Cerottini, Pedro Romero	12
18	Characteristics of a potent tumor vaccine-induced secondary anti-tumor T cell response. 2004 ·PubMed ·Yolanda D. Mahnke, Volker Schirrmacher	9
19	A novel tumour model system for the study of long-term protective immunity and immune T cell memory 2003 ·Cellular Immunology ·Yolanda D. Mahnke, Volker Schirrmacher	12
20	Bone marrow as a priming site for T-cell responses to blood-borne antigen 2003 ·Nature Medicine ·Markus Feuerer, Philipp Beckhove, Natalio Garbi, Yolanda D. Mahnke, Andreas Limmer, Mirja Hommel, Günter J. Hämmerling, Bruno Kyewski, Alf Hamann, Viktor Umansky, Volker Schirrmacher	266

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact